Roberto Gerli (R Gerli)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 13

Top Topics

Chronic Rhinosinusitis

Disease Activity

Rheumatoid Arthritis

Top Venues

Rheumatology international

Annals of the rheumatic diseases

Open forum infectious diseases

This page only lists publications with an associated author ORCID identifier.

Publications

Lorenza Bruno, Martina Mandarano, Guido Bellezza, Angelo Sidoni, Roberto Gerli, Elena Bartoloni, Carlo Perricone
Polyangiitis overlap syndrome: a rare clinical entity. Rheumatology international 43 (3) (2023)
Lorenza Bruno, Martina Mandarano, Guido Bellezza, Angelo Sidoni, Roberto Gerli, Elena Bartoloni, Carlo Perricone
Polyangiitis overlap syndrome: a rare clinical entity. Rheumatology international 43 (3) (2023)
Lorenza Bruno, Martina Mandarano, Guido Bellezza, Angelo Sidoni, Roberto Gerli, Elena Bartoloni, Carlo Perricone
Polyangiitis overlap syndrome: a rare clinical entity. Rheumatology international 43 (3) (2023)
Lorenza Bruno, Martina Mandarano, Guido Bellezza, Angelo Sidoni, Roberto Gerli, Elena Bartoloni, Carlo Perricone
Polyangiitis overlap syndrome: a rare clinical entity. Rheumatology international 43 (3) (2023)
Lorenza Bruno, Martina Mandarano, Guido Bellezza, Angelo Sidoni, Roberto Gerli, Elena Bartoloni, Carlo Perricone
Polyangiitis overlap syndrome: a rare clinical entity. Rheumatology international 43 (3) (2023)
Lorenza Bruno, Martina Mandarano, Guido Bellezza, Angelo Sidoni, Roberto Gerli, Elena Bartoloni, Carlo Perricone
Polyangiitis overlap syndrome: a rare clinical entity. Rheumatology international (2023)
Giacomo Cafaro, Elena Bartoloni, Chiara Baldini, Franco Franceschini, Valeria Riccieri, Antonella Fioravanti, Marco Fornaro, Anna Ghirardello, Boaz Palterer, Maria Infantino, Amelia Rigon, Stefania Del Rosso, Roberto Gerli, Danilo Villalta, Nicola Bizzaro, null null, null null
Autoantibody status according to multiparametric assay accurately estimates connective tissue disease classification and identifies clinically relevant disease clusters. RMD open 9 (3) (2023)
Roberto Caporali, Giorgio Sesti, Paola Cipriani, Roberto Gerli, Roberto Giacomelli
Correspondence on 'Disease activity, cytokines, chemokines and the risk of incident diabetes in rheumatoid arthritis'. Annals of the rheumatic diseases (2021)
Carlo Perricone, Elena Bartoloni, Giacomo Cafaro, Roberto Caporali, Roberto Gerli
Correspondence on 'Anti-inflammatory therapy for COVID-19 infection: the case for colchicine'. Annals of the rheumatic diseases (2021)
Fabiola Atzeni, Alessandra Alciati, Fausto Salaffi, Marco Di Carlo, Laura Bazzichi, Marcello Govoni, Giovanni Biasi, Manuela Di Franco, Flavio Mozzani, Elisa Gremese, Lorenzo Dagna, Alberto Batticciotto, Fabio Fischetti, Roberto Giacomelli, Serena Guiducci, Giuliana Guggino, Mario Bentivegna, Roberto Gerli, Carlo Salvarani, Gianluigi Bajocchi, Marco Ghini, Florenzo Iannone, Valeria Giorgi, Sonia Farah, Sara Bonazza, Stefano Barbagli, Chiara Gioia, Noemi Giuliana Marino, Annunziata Capacci, Giulio Cavalli, Antonella Cappelli, Francesco Carubbi, Francesca Nacci, Ilenia Riccucci, Maurizio Cutolo, Luigi Sinigaglia, Piercarlo Sarzi-Puttini
The association between body mass index and fibromyalgia severity: data from a cross-sectional survey of 2339 patients. Rheumatology advances in practice 5 (1) (2021)
Carlo Perricone, Roberto Gerli
Being a rheumatologist and a patient with a rheumatic disease today: A perspective at the time of COVID-19. European journal of rheumatology 7 (Suppl 2) (2020)
Daniela Francisci, Matteo Pirro, Elisabetta Schiaroli, Massimo R Mannarino, Sabrina Cipriani, Vanessa Bianconi, Alessia Alunno, Francesco Bagaglia, Onelia Bistoni, Emanuela Falcinelli, Loredana Bury, Roberto Gerli, Elmo Mannarino, Raffaele De Caterina, Franco Baldelli
Maraviroc Intensification Modulates Atherosclerotic Progression in HIV-Suppressed Patients at High Cardiovascular Risk. A Randomized, Crossover Pilot Study. Open forum infectious diseases 6 (4) (2019)
Elena Bartoloni, C Baldini, S De Vita, R Priori, R Giacomelli, V Bini, Roberto Gerli
Interplay of anti-SSA/SSB status and hypertension in determining cardiovascular risk in primary Sjögren's syndrome. Journal of internal medicine 287 (2) (2019)